ATRC
AtriCure, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$58.10
−1.73%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.01
- Revenue estimate
- $151.2M
Latest reported
- Last report date
- Jul 23, 2026
- EPS actual
- $0.18
- EPS estimate
- -$0.00
- Revenue actual
- $153.6M
- Revenue estimate
- $151.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +2818.1%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $57
- PT range
- $50 – $64
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 23, 2026 | -$0.00 | $0.18 | Beat 10878.44% | $153.6M |
| May 5, 2026 | -$0.07 | $0.00 | Beat 103.14% | $141.2M |
| Feb 17, 2026 | -$0.04 | $0.04 | Beat 200.00% | $140.5M |
| Oct 29, 2025 | -$0.11 | -$0.01 | Beat 90.91% | $134.3M |
| Jul 29, 2025 | -$0.15 | -$0.02 | Beat 86.67% | $136.1M |
| Apr 29, 2025 | -$0.25 | -$0.14 | Beat 44.00% | $123.6M |
| Feb 12, 2025 | -$0.23 | -$0.08 | Beat 65.22% | $124.3M |
| May 1, 2024 | -$0.21 | -$0.25 | Miss -19.05% | $108.9M |
| Feb 15, 2024 | -$0.22 | -$0.21 | Beat 4.55% | $106.5M |
| Nov 1, 2023 | -$0.30 | -$0.20 | Beat 33.33% | $98.3M |
| Jul 25, 2023 | -$0.27 | -$0.12 | Beat 55.56% | $100.9M |
| May 2, 2023 | -$0.34 | -$0.23 | Beat 32.35% | $93.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026